UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL

PloS one, 2017-05, Vol.12 (5), p.e0173353-e0173353

2017

Volltextzugriff (PDF)

Matching-adjusted indirect comparison via a polynomial-based non-linear optimization method

Journal of comparative effectiveness research, 2022-06, Vol.11 (8), p.551-561

2022

Volltextzugriff (PDF)

Interferon β-1a in MS: Results following development of neutralizing antibodies in PRISMS

Neurology, 2005-07, Vol.65 (1), p.48-55

2005

Volltextzugriff (PDF)

5613341 REAL‐WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US

HemaSphere, 2023-04, Vol.7 (S1), p.43-44

2023

Volltextzugriff (PDF)

VP90 Which Matching Adjusted Indirect Comparison Method Is Best?

International journal of technology assessment in health care, 2019, Vol.35 (S1), p.94-95

2019

Volltextzugriff (PDF)

The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs

Journal of comparative effectiveness research, 2016-11, Vol.5 (6), p.569-579

2016

Volltextzugriff (PDF)

Time Off From Work: a Matched Comparison of Fingolimod and BRACE in Patients with Multiple Sclerosis from the PANGAEA and PEARL Studies (P7.019)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Effectiveness of Fingolimod Compared with Interferons and Glatiramer Acetate for the Treatment of Multiple Sclerosis: A Matched Comparison of Treatments from the PANGAEA and PEARL Studies (P3.253)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Under-reporting of motor vehicle traffic crash victims in New Zealand

Accident analysis and prevention, 2001-05, Vol.33 (3), p.353-359

2001

Volltextzugriff (PDF)

Review and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept

Expert review of pharmacoeconomics & outcomes research, 2016-11, Vol.16 (6), p.793-801

2016

Volltextzugriff (PDF)

Results from a 9-year Intensive Safety Surveillance Scheme (IS3) in miglustat (Zavesca®)-treated patients

Pharmacoepidemiology and drug safety, 2015-03, Vol.24 (3), p.329-333

2015

Volltextzugriff (PDF)

An evaluation of the general effect of the New Zealand graduated driver licensing system on motorcycle traffic crash hospitalisations

Accident analysis and prevention, 1999-11, Vol.31 (6), p.651-661

1999

Volltextzugriff (PDF)

Dying to go on holiday

Australian and New Zealand journal of public health, 2000-12, Vol.24 (6), p.607-609

2000

Volltextzugriff (PDF)

Effect of Fingolimod in Patients with No Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P07.124)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

Effects of Fingolimod on Disability Progression in Patients with Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P04.128)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

Achieving compliance with pool fencing legislation in New Zealand: a survey of regulatory authorities

Injury prevention, 1999-06, Vol.5 (2), p.114-118

1999

Volltextzugriff (PDF)

Update From the International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

Molecular genetics and metabolism, 2012-02, Vol.105 (2), p.S51-S51

2012

Volltextzugriff (PDF)

Hepatic reactions during treatment of multiple sclerosis with interferon-β-1a: Incidence and clinical significance

Drug safety, 2003-11, Vol.26 (11), p.815-827

2003

Volltextzugriff (PDF)

Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance

Drug safety, 2003, Vol.26 (11), p.815

2003

Volltextzugriff (PDF)

Trends in motorcyclist and occupant fatalities and serious injuries due to traffic crashes

New Zealand medical journal, 1998-07, Vol.111 (1070), p.267

1998

Volltextzugriff (PDF)

Head injuries to bicyclists and the New Zealand bicycle helmet law

Accident analysis and prevention, 2000-07, Vol.32 (4), p.565-573

2000

Volltextzugriff (PDF)

The work-related fatal injury study : numbers, rates and trends of work-related fatal injuries in New Zealand 1985-1994

New Zealand medical journal, 2001-01, Vol.114 (1124), p.6-10

Feyer, Anne-Marie

2001

Volltextzugriff (PDF)

Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMS

Neurology, 2005-07, Vol.65 (1), p.48

2005

Volltextzugriff (PDF)

Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1a: Incidence and Clinical Significance

Drug safety, 2003, Vol.26 (11), p.815-827

2003

Volltextzugriff (PDF)

Temporal patterns of injury during a rugby season

Journal of science and medicine in sport, 2000-06, Vol.3 (2), p.97-109

2000

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(55)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Humans
(24)
Life Sciences & Biomedicine
(21)
Female
(17)
Male
(14)
Adult
(13)
Middle Aged
(9)
Adolescent
(8)
Aged
(8)
New Zealand - Epidemiology
(6)
Public, Environmental & Occupational Health
(6)
Technology
(6)
Biological And Medical Sciences
(5)
Child
(5)
Child, Preschool
(5)
Medical Sciences
(5)
Physical Sciences
(5)
Social Sciences
(5)
Treatment Outcome
(5)
Accidents, Traffic - Statistics & Numerical Data
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL

Matching-adjusted indirect comparison via a polynomial-based non-linear optimization method

Interferon β-1a in MS: Results following development of neutralizing antibodies in PRISMS

5613341 REAL‐WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US

VP90 Which Matching Adjusted Indirect Comparison Method Is Best?

The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs

Time Off From Work: a Matched Comparison of Fingolimod and BRACE in Patients with Multiple Sclerosis from the PANGAEA and PEARL Studies (P7.019)

Effectiveness of Fingolimod Compared with Interferons and Glatiramer Acetate for the Treatment of Multiple Sclerosis: A Matched Comparison of Treatments from the PANGAEA and PEARL Studies (P3.253)

Under-reporting of motor vehicle traffic crash victims in New Zealand

Review and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept

Results from a 9-year Intensive Safety Surveillance Scheme (IS3) in miglustat (Zavesca®)-treated patients

An evaluation of the general effect of the New Zealand graduated driver licensing system on motorcycle traffic crash hospitalisations

Dying to go on holiday

Effect of Fingolimod in Patients with No Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P07.124)

Effects of Fingolimod on Disability Progression in Patients with Disability as Measured by EDSS at Baseline: Post-Hoc Analyses of FREEDOMS I and II (P04.128)

Achieving compliance with pool fencing legislation in New Zealand: a survey of regulatory authorities

Update From the International Registry for Niemann-Pick Disease Type C (NP-C) in Clinical Practice

Hepatic reactions during treatment of multiple sclerosis with interferon-β-1a: Incidence and clinical significance

Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance

Trends in motorcyclist and occupant fatalities and serious injuries due to traffic crashes

Head injuries to bicyclists and the New Zealand bicycle helmet law

The work-related fatal injury study : numbers, rates and trends of work-related fatal injuries in New Zealand 1985-1994

Interferon beta-1a in MS: results following development of neutralizing antibodies in PRISMS

Hepatic Reactions During Treatment of Multiple Sclerosis with Interferon-??-1a: Incidence and Clinical Significance

Temporal patterns of injury during a rugby season

Suchergebnisse filtern